306 related articles for article (PubMed ID: 29149811)
1. Testing the Actions of a Multi-action Emollient: Patient's Acceptability Determines Product Efficacy.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):110-116. PubMed ID: 29149811
[TBL] [Abstract][Full Text] [Related]
2. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.
Hon KL; Pong NH; Wang SS; Lee VW; Luk NM; Leung TF
Drugs R D; 2013 Mar; 13(1):37-42. PubMed ID: 23456759
[TBL] [Abstract][Full Text] [Related]
3. Emollient Acceptability in Childhood Atopic Dermatitis: Not All Emollients are Equal.
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Lee VW; Leung TF
Curr Pediatr Rev; 2018; 14(2):117-122. PubMed ID: 28578641
[TBL] [Abstract][Full Text] [Related]
4. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
5. Estimating emollient usage in patients with eczema.
Hon KL; Ching GK; Leung TF; Choi CY; Lee KK; Ng PC
Clin Exp Dermatol; 2010 Jan; 35(1):22-6. PubMed ID: 19489850
[TBL] [Abstract][Full Text] [Related]
6. Testing an Ectoin Containing Emollient for Atopic Dermatitis.
Hon KL; Kung JS; Ng WGG; Leung TF
Curr Pediatr Rev; 2019; 15(3):191-195. PubMed ID: 30987568
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
Chamlin SL; Kao J; Frieden IJ; Sheu MY; Fowler AJ; Fluhr JW; Williams ML; Elias PM
J Am Acad Dermatol; 2002 Aug; 47(2):198-208. PubMed ID: 12140465
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial.
Hon KL; Tsang YC; Lee VW; Pong NH; Ha G; Lee ST; Chow CM; Leung TF
J Dermatolog Treat; 2016; 27(2):156-62. PubMed ID: 26270469
[TBL] [Abstract][Full Text] [Related]
9. A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares.
Angelova-Fischer I; Neufang G; Jung K; Fischer TW; Zillikens D
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 3():9-15. PubMed ID: 24702445
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation.
Breternitz M; Kowatzki D; Langenauer M; Elsner P; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(1):39-45. PubMed ID: 18025807
[TBL] [Abstract][Full Text] [Related]
11. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe?
Hon KL; Wang SS; Lee KK; Lee VW; Leung TF; Ip M
J Drugs Dermatol; 2012 Jul; 11(7):861-4. PubMed ID: 22777230
[TBL] [Abstract][Full Text] [Related]
12. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
Danby SG; Andrew PV; Taylor RN; Kay LJ; Chittock J; Pinnock A; Ulhaq I; Fasth A; Carlander K; Holm T; Cork MJ
Clin Exp Dermatol; 2022 Jun; 47(6):1154-1164. PubMed ID: 35167133
[TBL] [Abstract][Full Text] [Related]
13. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
14. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis.
Hon KL; Wong KY; Leung TF; Chow CM; Ng PC
Am J Clin Dermatol; 2008; 9(1):45-50. PubMed ID: 18092843
[TBL] [Abstract][Full Text] [Related]
15. Pseudoceramide for childhood eczema: does it work?
Hon KL; Wang SS; Lau Z; Lee HC; Lee KK; Leung TF; Luk NM
Hong Kong Med J; 2011 Apr; 17(2):132-6. PubMed ID: 21471593
[TBL] [Abstract][Full Text] [Related]
16. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
[TBL] [Abstract][Full Text] [Related]
17. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and Staphylococcus aureus colonization/infection in childhood atopic dermatitis.
Hon KL; Tsang YC; Pong NH; Ng C; Ip M; Leung TF
J Dermatolog Treat; 2016; 27(3):235-40. PubMed ID: 26558412
[TBL] [Abstract][Full Text] [Related]
19. Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis.
Bianchi P; Theunis J; Casas C; Villeneuve C; Patrizi A; Phulpin C; Bacquey A; Redoulès D; Mengeaud V; Schmitt AM
Pediatr Dermatol; 2016; 33(2):165-71. PubMed ID: 27001317
[TBL] [Abstract][Full Text] [Related]
20. Are skin equipment for assessing childhood eczema any good?
Hon KL; Kung JSC; Ng WG; Tsang KYC; Cheng N; Leung TF
J Dermatolog Treat; 2021 Feb; 32(1):45-48. PubMed ID: 29460656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
